BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 9712097)

  • 1. Enhanced interleukin 6 production by cultured fibroblasts from patients with systemic sclerosis in response to platelet derived growth factor.
    Takemura H; Suzuki H; Fujisawa H; Yuhara T; Akama T; Yamane K; Kashiwagi H
    J Rheumatol; 1998 Aug; 25(8):1534-9. PubMed ID: 9712097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis.
    Chizzolini C; Raschi E; Rezzonico R; Testoni C; Mallone R; Gabrielli A; Facchini A; Del Papa N; Borghi MO; Dayer JM; Meroni PL
    Arthritis Rheum; 2002 Jun; 46(6):1602-13. PubMed ID: 12115192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated levels of platelet derived growth factor and transforming growth factor-beta 1 in bronchoalveolar lavage fluid from patients with scleroderma.
    Ludwicka A; Ohba T; Trojanowska M; Yamakage A; Strange C; Smith EA; Leroy EC; Sutherland S; Silver RM
    J Rheumatol; 1995 Oct; 22(10):1876-83. PubMed ID: 8991985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis.
    Distler JH; Jüngel A; Kowal-Bielecka O; Michel BA; Gay RE; Sprott H; Matucci-Cerinic M; Chilla M; Reich K; Kalden JR; Müller-Ladner U; Lorenz HM; Gay S; Distler O
    Arthritis Rheum; 2005 Mar; 52(3):856-64. PubMed ID: 15751077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of hepatocyte growth factor and its receptor (c-met) in skin fibroblasts from patients with systemic sclerosis.
    Kawaguchi Y; Harigai M; Hara M; Fukasawa C; Takagi K; Tanaka M; Tanaka E; Nishimagi E; Kamatani N
    J Rheumatol; 2002 Sep; 29(9):1877-83. PubMed ID: 12233882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha.
    Chizzolini C; Parel Y; De Luca C; Tyndall A; Akesson A; Scheja A; Dayer JM
    Arthritis Rheum; 2003 Sep; 48(9):2593-604. PubMed ID: 13130479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of PDGF, IL-1alpha, and BMP2/4 on corneal fibroblast chemotaxis: expression of the platelet-derived growth factor system in the cornea.
    Kim WJ; Mohan RR; Mohan RR; Wilson SE
    Invest Ophthalmol Vis Sci; 1999 Jun; 40(7):1364-72. PubMed ID: 10359318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast proliferation by bleomycin stimulated peripheral blood mononuclear cell factors.
    Yamamoto T; Katayama I; Nishioka K
    J Rheumatol; 1999 Mar; 26(3):609-15. PubMed ID: 10090171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autocrine activation by interleukin 1alpha induces the fibrogenic phenotype of systemic sclerosis fibroblasts.
    Kawaguchi Y; McCarthy SA; Watkins SC; Wright TM
    J Rheumatol; 2004 Oct; 31(10):1946-54. PubMed ID: 15468358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
    Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
    Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor induction regulates the synergistic effects of substance P with IL-1 and platelet-derived growth factor on the proliferation of bone marrow fibroblasts.
    Rameshwar P; Poddar A; Zhu G; Gascón P
    J Immunol; 1997 Apr; 158(7):3417-24. PubMed ID: 9120302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transcription factor Fra-2 regulates the production of extracellular matrix in systemic sclerosis.
    Reich N; Maurer B; Akhmetshina A; Venalis P; Dees C; Zerr P; Palumbo K; Zwerina J; Nevskaya T; Gay S; Distler O; Schett G; Distler JH
    Arthritis Rheum; 2010 Jan; 62(1):280-90. PubMed ID: 20039427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast function in psoriatic arthritis. II. Increased expression of beta platelet derived growth factor receptors and increased production of growth factor and cytokines.
    Espinoza LR; Espinoza CG; Cuéllar ML; Scopelitis E; Silveira LH; Grotendorst GR
    J Rheumatol; 1994 Aug; 21(8):1507-11. PubMed ID: 7983655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obligatory action of polypeptide growth factors for the IL-1-mediated prostaglandin E2 production in fibroblasts. Potential role of growth factors in modulation of tissue response to IL-1.
    Chiou WJ; Bonin PD; Singh JP
    J Immunol; 1990 Oct; 145(7):2155-60. PubMed ID: 2144546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased production of interleukin 6 and interleukin 8 in scleroderma fibroblasts.
    Kadono T; Kikuchi K; Ihn H; Takehara K; Tamaki K
    J Rheumatol; 1998 Feb; 25(2):296-301. PubMed ID: 9489822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-derived growth factor and inflammatory cytokines have differential effects on the expression of integrins alpha 1 beta 1 and alpha 5 beta 1 by human dermal fibroblasts in vitro.
    Gailit J; Xu J; Bueller H; Clark RA
    J Cell Physiol; 1996 Nov; 169(2):281-9. PubMed ID: 8908195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin 1 receptor on fibroblasts from systemic sclerosis patients induces excessive functional responses to interleukin 1 beta.
    Kawaguchi Y; Harigai M; Suzuki K; Hara M; Kobayashi K; Ishizuka T; Matsuki Y; Tanaka N; Nakamura H
    Biochem Biophys Res Commun; 1993 Jan; 190(1):154-61. PubMed ID: 8422241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of type I collagen production by dermal fibroblasts upon contact with activated T cells: different sensitivity to inhibition between systemic sclerosis and control fibroblasts.
    Chizzolini C; Rezzonico R; Ribbens C; Burger D; Wollheim FA; Dayer JM
    Arthritis Rheum; 1998 Nov; 41(11):2039-47. PubMed ID: 9811060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased interleukin-17 production in patients with systemic sclerosis.
    Kurasawa K; Hirose K; Sano H; Endo H; Shinkai H; Nawata Y; Takabayashi K; Iwamoto I
    Arthritis Rheum; 2000 Nov; 43(11):2455-63. PubMed ID: 11083268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific inhibition of human skin fibroblast chemotaxis to platelet-derived growth factor A-chain homodimer by transforming growth factor-beta1.
    Soma Y; Mizoguchi M; Yamane K; Yazawa N; Kubo M; Ihn H; Kikuchi K; Tamaki K
    Arch Dermatol Res; 2002 Feb; 293(12):609-13. PubMed ID: 11875643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.